The US Food and Drug Administration Provides a Pathway for Licensing Vaccines for Global Diseases

1. Food and Drug Administration 2008 Guidance for industry: General principles for the development of vaccines to protect against global infectious diseases. Available: http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm074762.htm. Accessed 17 June 2009

2. LaForceFM

KondeK

VivianiS

PreziosiMP

2007 The Meningitis Vaccine Project. Vaccine 25 (Suppl 1) A97 A100

3. BejonP

LusinguJ

OlotuA

LeachA

LievensM

2008 Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 359 2521 2532

4. SkeikyYAW

SadoffJC

2006 Advances in tuberculosis vaccine strategies. Nat Rev Microbiol 4 469 476

5. JohnstonMI

FauciAS

2008 An HIV vaccine—Challenges and prospects. N Engl J Med 359 888 890

6. WalkerRI

2005 New vaccines against enteric bacteria for children in less developed countries. Expert Rev Vaccines 4 807 812

7. HotezPJ

MolyneuxDH

FenwickA

KumaresanJ

SachsSE

2007 Control of neglected tropical diseases. N Engl J Med 357 1018 1027

8. BrennanMJ

FruthU

MilstienJ

TiernanR

de Andrade NishiokaS

2007 Development of new tuberculosis vaccines: A global perspective on regulatory issues. PLoS Med 4 e252 doi:10.1371/journal.pmed.0040252

9. European Medicines Agency 2005 Guideline on procedural aspects regarding a CHMP scientific opinion in the context of cooperation with the World Health Organisation (WHO) for the evaluation of medicinal products intended exclusively for markets outside the community. Available: http://www.emea.europa.eu/pdfs/human/regaffair/557904en.pdf. Accessed 17 June 2009

10. World Health Organization 2006 Procedures for assessing the acceptability of vaccines for purchase by United Nations agencies. Available: http://www.path.org/vaccineresources/files/Procedures_acceptability_purchase_by_UN.pdf. Accessed 17 June 2009

11. MilstienJ

DellepianeN

LambertS

BelgharbiL

RollsC

2002 Vaccine quality—Can a single standard be defined? Vaccine 2956 1 4

12. [No authors listed]

1994 Recommendations of the Advisory Committee on Immunization Practices (ACIP): Typhoid immunization. MMWR 43 1 7

13. [No authors listed]

1993 Recommendations of the Advisory Committee on Immunization Practices (ACIP): Inactivated Japanese encephalitis virus vaccine. MMWR 42 1 15

14. OlinP

RasmussenF

GustafssonL

HallanderHO

HeijbelH

1997 Randomized controlled trial of two-component, three-component and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 350 1569 1577

15. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research 2008 Guidance for industry: Tropical disease priority review vouchers. Available: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM080599.pdf. Accessed 23 June 2009